Neurocosmetics in Skincare—The Fascinating World of Skin–Brain Connection: A Review to Explore Ingredients, Commercial Products for Skin Aging, and Cosmetic Regulation

The “modern” cosmetology industry is focusing on research devoted to discovering novel neurocosmetic functional ingredients that could improve the interactions between the skin and the nervous system. Many cosmetic companies have started to formulate neurocosmetic products that exhibit their activity on the cutaneous nervous system by affecting the skin’s neuromediators through different mechanisms of action. This review aims to clarify the definition of neurocosmetics, and to describe the features of some functional ingredients and products available on the market, with a look at the regulatory aspect. The attention is devoted to neurocosmetic ingredients for combating skin stress, explaining the stress pathways, which are also correlated with skin aging. “Neuro-relaxing” anti-aging ingredients derived from plant extracts and neurocosmetic strategies to combat inflammatory responses related to skin stress are presented. Afterward, the molecular basis of sensitive skin and the suitable neurocosmetic ingredients to improve this problem are discussed. With the aim of presenting the major application of Botox-like ingredients as the first neurocosmetics on the market, skin aging is also introduced, and its theory is presented. To confirm the efficacy of the cosmetic products on the market, the concept of cosmetic claims is discussed

Removal of an Azo Textile Dye from Wastewater by Cyclodextrin-Epichlorohydrin Polymers

Native cyclodextrins (CDs), α-, β- and γ-CDs, were employed to synthetise three different cyclodextrin-based polymers using epichlorohydrin (EPI) as a cross-linker. These polymers were applied as adsorbent material to remove an azo textile dye, Direct Blue 78 (DB78), from water. The formation of inclusion complexes between the alone CDs and DB78 molecules were first studied in aqueous solutions. Then, adsorption experiments of the dye were performed by means of cyclodextrin/epichlorohydrin (CD/EPI) polymers. The effects of various parameters, such as contact time, adsorbent dosage, initial dye concentration, pH and temperature, were examined to determine the better adsorption conditions. The equilibrium isotherms and the adsorption kinetics were also analysed using opportune mathematic models. The chemical-physical characteristics and the morphology of the adsorbent polymers were, respectively, observed by differential scanning calorimetry and field emission scanning electron microscope. The CD/EPI polymers showed a very good ability in the removal of DB78 from aqueous solution; indeed, the maximum efficiencies in the dye removal were found to be about 99% for β-CD/EPI polymer and about 97% for γ-CD/EPI polymer, at pH 6 and 25°C conditions. It is possible to assume that the good adsorbent aptitude of CD/EPI polymers is due to their double peculiarity to include the dye in the inner cavity of CDs and to adsorb the dye on their porous surfaces by physical interaction

Molecular interactions, characterization and photoactivity of Chlorophyll a/chitosan/2-HP-β-cyclodextrin composite films as functional and active surfaces for ROS production

Novel photosensitizing film based on the natural hybrid polymer Chitosan/2-hydroxy-propyl-β-Cyclodextrin (CH/CD) is synthesized introducing Chlorophyll a (CH/CD/Chla) as a photoactive agent for possible application in antimicrobial photodynamic therapy (PDT). The polymer absorbs visible light, in turn able to generate reactive oxygen species (ROS) and, therefore it can be used as environmental friendly and biodegradable polymeric photosensitizer (PS). The modified film is characterized by means of different spectroscopic, calorimetric, diffraction techniques and microscopic imaging methods including time-resolved absorption spectroscopy. UV–Vis, FTIR-ATR and X-ray Photoelectron Spectroscopy (XPS) analyses suggest that Chla shows a strong affinity toward Chitosan introducing interactions with amino groups present on the polymer chains. Nanosecond laser flash photolysis technique provides evidence for the population of the excited triplet state of Chla. Photogeneration of singlet oxygen is demonstrated by both direct detection by using infrared luminescence spectroscopy and chemical methods based on the use of suitable traps. Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM) and Differential Scanning Calorimetry (DSC) analyses confirm also the occurrence of structural changes both on the film surface and within the film layer induced by the insertion of the pigment. Moreover, X-ray Diffraction data (XRD) shows the existence of an amorphous phase for the chitosan films in all the compared conditions

What Is New in the Treatment of Smoldering Multiple Myeloma?

Smoldering multiple myeloma (SMM), an asymptomatic plasma cell neoplasm, is currently diagnosed according to the updated IMWG criteria, which reflect an intermediate tumor mass between monoclonal gammopathy of undetermined significance (MGUS) and active MM. However, SMM is a heterogeneous entity and individual case may go from an “MGUS-like” behavior to “early MM” with rapid transformation into symptomatic disease. This wide range of clinical outcomes poses challenges for prognostication and management of individual patients. However, initial studies showed a benefit in terms of progression or even survival for early treatment of high-risk SMM patients. While outside of clinical trials the conventional approach to SMM generally remains that of close observation, these studies raised the question of whether early treatment should be offered in high-risk patients, prompting evaluation of several different therapeutic approaches with different goals. While delay of progression to MM with a non-toxic treatment is clearly achievable by early treatment, a convincing survival benefit still needs to be proven by independent studies. Furthermore, if SMM is to be considered less biologically complex than MM, early treatment may offer the chance of cure that is currently not within reach of any active MM treatment. In this paper, we present updated results of completed or ongoing clinical trials in SMM treatment, highlighting areas of uncertainty and critical issues that will need to be addressed in the near future before the “watch and wait” paradigm in SMM is abandoned in favor of early treatmen

The synergistic action of cyclodextrin-based adsorbent and advanced oxidation processes for sulfamethoxazole removal from water

In this work, the removal of sulfamethoxazole from water was studied by adsorption on a cyclodextrin–epichlorohydrin copolymer and through Advanced Oxidation Processes. The adsorption was efficient and fast, requiring only 10 min to reach the equilibrium; it was also highly favored, with adsorption efficiency higher than 80%, at slightly acidic pH and at room temperature. The desorption of sulfamethoxazole was obtained by raising the temperature to 80 °C. The regenerated polymer has been reused multiple times without any loss in performance, allowing a reduction in costs associated with the process. As an alternative method to regenerate the adsorbent material, the photodegradation of sulfamethoxazole adsorbed on the polymer alone and in the presence of TiO2 as a catalyst through continuous irradiation with UV light and Pulsed Light was attempted and studied. For this purpose, polymeric adsorbents containing different amounts of TiO2 were synthesized and tested. The Pulsed Light showed the highest efficiency since it allowed the complete removal of sulfamethoxazole, regardless of the presence of TiO2 which, however, reduces adsorption efficiency of the material. Furthermore, a qualitative assessment of formed pulsed light by-products was also attempted. The remains of SMX in solution were decomposed by Pulsed Light technology and the effect of the presence of hydrogen peroxide on the photodegradation process was also studied. Despite the presence of by-products after Advanced Oxidation Processes, the procedure proposed in this work is effective and easy to apply to water treatment plants, thanks to the use of environmental-friendly adsorbents and light sources

Green procedure for one-pot synthesis of azelaic acid derivatives using metal catalysis

Background & Objective: A green one-pot synthesis of oleic acid (1) derivatives is promoted by Rare Earth Metal (REM) triflates and commercial Molybdenum dioxo dichloride (MoCl 2 O 2 ) in the presence hydrogen peroxide as a green oxidant. Results: The protocol permits to govern the oxidation selectivity by simply choosing the proper combination of Mo and Sc catalysts. Conclusion: Methyl oleate epoxide 2a and azelaic acid 6 thus obtained are valuable industrial intermediates for synthesizing bio-compostable plastics, plasticizers of PVC, lubricating oils, cosmetics and pharmaceuticals (bactericides, anti-inflammatories, etc.)

Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial

: As lactoferrin is a nutritional supplement with proven antiviral and immunomodulatory abilities, it may be used to improve the clinical course of COVID-19. The clinical efficacy and safety of bovine lactoferrin were evaluated in the LAC randomized double-blind placebo-controlled trial. A total of 218 hospitalized adult patients with moderate-to-severe COVID-19 were randomized to receive 800 mg/die oral bovine lactoferrin (n = 113) or placebo (n = 105), both given in combination with standard COVID-19 therapy. No differences in lactoferrin vs. placebo were observed in the primary outcomes: the proportion of death or intensive care unit admission (risk ratio of 1.06 (95% CI 0.63-1.79)) or proportion of discharge or National Early Warning Score 2 (NEWS2) ≤ 2 within 14 days from enrollment (RR of 0.85 (95% CI 0.70-1.04)). Lactoferrin showed an excellent safety and tolerability profile. Even though bovine lactoferrin is safe and tolerable, our results do not support its use in hospitalized patients with moderate-to-severe COVID-19